Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to optimize clinical research enrollment.
RapidPulse is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke
410 Medical is a medical device company dedicated to developing innovative products that enable frontline medical providers to improve care.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
Shattuck Labs is a biotechnology company that provides novel class biologic medicines for the treatment of cancer and autoimmune disease.
CREATE Medicines is a biotech company developing in vivo CAR therapies using mRNA-LNP immune cell programming technology.
Incyclix Bio develops small molecule inhibitors of CDKs for the treatment of advanced and resistant cancers.
Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients.
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
Boomerang Medical is a bioelectronic medical enterprise.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.
Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.
GeneCentric Therapeutics develops and commercializes molecular diagnostic tests for oncologists and patients.
GoCheck, creator of GoCheck Kids, helps primary care networks implement pediatric vision screening.
Trefoil is a biotechnology company that brings forward novel engineered FGF-1 compounds to treat endothelial cell mediated diseases.
Altis Biosystems is a biotechnology company developing research tools for the pharma and biotech industries.
Huma is a provider of business intelligence platform built to automate healthcare through human language.
Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Tune Therapeutics is an epigenetic programming platform for the treatment of disease.
Ten63 Therapeutics is a venture-backed startup developing durable therapeutics against some of the world's most lethal diseases.
Wildflower is a women’s health solutions company, specializing in digital and value-based care.
Synaptrix is a healthcare company that offers medical products for postoperative pain treatment.
Hatteras Venture Partners has invested in 63 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Hatteras Venture Partners's top investment sectors include Health Care, Biotechnology, Therapeutics, Medical, Medical Device. The firm invests across 23 different industry categories.
Among tracked funding rounds, Tune Therapeutics received $175.0M in a Series B round. Hatteras Venture Partners's total known invested capital is $2.1B.
Hatteras Venture Partners's average investment size is $32.8M across its portfolio of 63 companies.
Recent Hatteras Venture Partners portfolio additions include BEKHealth, RapidPulse, 410 Medical, Clearside Biomedical, Ladder Health. These companies were founded in 2020 or later.